{
    "organizations": [],
    "uuid": "c322471ac4d5382714aa5a19df0f63def1e115e4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-abeona-receives-fda-regenerative-m/brief-abeona-receives-fda-regenerative-medicine-advanced-therapy-status-for-experimental-gene-therapy-for-rare-skin-disorder-idUSFWN1PO108",
    "ord_in_thread": 0,
    "title": "BRIEF-Abeona Receives FDA Regenerative Medicine Advanced Therapy Status For Experimental Gene Therapy For Rare Skin Disorder",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 29, 2018 / 1:51 PM / in 10 minutes BRIEF-Abeona Receives FDA Regenerative Medicine Advanced Therapy Status For Experimental Gene Therapy For Rare Skin Disorder Reuters Staff \nJan 29 (Reuters) - Abeona Therapeutics Inc: \n* ABEONA RECEIVES FDA REGENERATIVE MEDICINE ADVANCED THERAPY DESIGNATION FOR EB-101 GENE THERAPY IN EPIDERMOLYSIS BULLOSA \n* ABEONA THERAPEUTICS - CONTINUES TO ENGAGE FDA ON ITS PIVOTAL PHASE 3 CLINICAL TRIAL DESIGN, AND WILL PROVIDE AN UPDATE ON RMAT PROGRAM IN COMING MONTHS Source text for Eikon: Further company coverage:",
    "published": "2018-01-29T15:50:00.000+02:00",
    "crawled": "2018-01-29T16:11:05.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "receives",
        "fda",
        "regenerative",
        "medicine",
        "advanced",
        "therapy",
        "status",
        "experimental",
        "gene",
        "therapy",
        "rare",
        "skin",
        "disorder",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "abeona",
        "therapeutic",
        "inc",
        "abeona",
        "receives",
        "fda",
        "regenerative",
        "medicine",
        "advanced",
        "therapy",
        "designation",
        "gene",
        "therapy",
        "epidermolysis",
        "bullosa",
        "abeona",
        "therapeutic",
        "continues",
        "engage",
        "fda",
        "pivotal",
        "phase",
        "clinical",
        "trial",
        "design",
        "provide",
        "update",
        "rmat",
        "program",
        "coming",
        "month",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}